[ad_1]
LONDON, Jan.3 (Xinhua) – University College Hospital, one of London’s largest hospitals, is struggling to accommodate the growing number of COVID-19 patients in the capital, warning that it is “on track to be almost COVID “. only “as intensive care patients increase, local media reported.
The hospital is struggling to convert operating rooms and stroke rooms into intensive care units, the London-based newspaper The Guardian reported.
Intensive care midwife Elaine Thorpe told the newspaper that she and her colleagues had installed 20 new intensive care beds on Christmas Eve, which were full by New Year’s Eve.
“The most important thing for me is that I am terribly worried about my team. The nurses have to break through. We go back to the levels we were before, where there was a nurse from the ICU (intensive care unit) taking care of what will be four patients, or more. And we have already had many tears “, was quoted by the main British newspaper.
The 500-bed hospital had 220 COVID-19 patients as of Thursday, and the numbers were up 5 percent a day, according to the newspaper.
The real pressure, however, is on intensive care, where there are now 70 seriously ill patients, and the number is increasing rapidly, Marcel Levi, executive director of the University College London Hospitals Trust, told the newspaper.
The latest figures from the British National Health Service (NHS) suggested that 629 patients with COVID-19 symptoms were admitted to London hospitals on December 27, 2020, 22 more than the previous day and extending a steady upward curve in The last weeks.
Across London, the number of hospital beds filled with COVID-19 patients stood at 5,371 on December 29, 2020, more than 400 above the previous day’s total and almost double the level on December 19, 2020. , according to the London Evening Standard. reported the newspaper.
As the world struggles to contain the pandemic, some countries are getting vaccinated with already licensed coronavirus vaccines.
Meanwhile, 232 candidate vaccines were still being developed around the world, 60 of them in clinical trials, in countries like Germany, China, France, Russia, Britain and the United States, according to the World Health Organization. Final product
